Characteristics | No PH (n = 250) | PH (n = 78) | P | No sICH (n = 270) | sICH (n = 58) | P |
---|---|---|---|---|---|---|
Age, y; median (IQR) | 68.00 (56.00–76.00) | 67.00 (58.50–74.00) | 0.897 | 67.00 (56.00–75.00) | 70.00 (62.25–75.00) | 0.082 |
Female, n (%) | 100 (40.00%) | 43 (55.13%) | 0.019 | 114 (42.22%) | 29 (50.00%) | 0.278 |
Atrial fibrillation, n (%) | 100 (40.00%) | 47 (60.26%) | 0.002 | 114 (42.22%) | 33 (56.90%) | 0.041 |
Hypertension, n (%) | 170 (68.00%) | 55 (70.51%) | 0.676 | 180 (66.67%) | 45 (77.59%) | 0.104 |
Diabetes, n (%) | 45 (18.00%) | 16 (20.51%) | 0.619 | 50 (18.52%) | 11 (18.97%) | 0.937 |
Hyperlipidemia, n (%) | 88 (35.20%) | 27 (34.62%) | 0.925 | 96 (35.56%) | 19 (32.76%) | 0.685 |
History of stroke, n (%) | 36 (14.40%) | 17 (21.79%) | 0.121 | 40 (14.81%) | 13 (22.41%) | 0.154 |
Smoking, n (%) | 77 (30.80%) | 23 (29.49%) | 0.826 | 85 (31.48%) | 15 (25.86%) | 0.399 |
Drinking, n (%) | 58 (23.20%) | 15 (19.23%) | 0.462 | 62 (22.96%) | 11 (18.97%) | 0.507 |
Baseline NIHSS, median (IQR) | 15.00 (12.00–18.00) | 18.50 (16.00–23.00) | < 0.001 | 15.00 (12.00–19.00) | 19.00 (16.00–23.75) | < 0.001 |
ASPECTS, median (IQR) | 7.00 (7.00–8.00) | 7.00 (6.00–7.00) | 0.009 | 7.00 (7.00–8.00) | 7.00 (6.00–7.00) | 0.003 |
Occluded artery, n (%) | 0.074 | 0.002 | ||||
ICA | 46 (18.40%) | 24 (30.77%) | 47 (17.41%) | 23 (39.66%) | ||
M1 of the MCA | 154 (61.60%) | 45 (57.69%) | 172 (63.70%) | 27 (46.55%) | ||
Posterior circulation | 32 (12.80%) | 5 (6.41%) | 31 (11.48%) | 6 (10.34%) | ||
Others | 18 (7.20%) | 4 (5.13%) | 20 (7.41%) | 2 (3.45%) | ||
IVT, n (%) | 78 (31.20%) | 25 (32.05%) | 0.888 | 85 (31.48%) | 18 (31.03%) | 0.947 |
Premorbid mRS, median (IQR) | 0.00 (0.00–0.00) | 0.00 (0.00–0.00) | 0.321 | 0.00 (0.00–0.00) | 0.00 (0.00–0.00) | 0.425 |
Stroke etiology, n (%) | 0.028 | 0.106 | ||||
LAA | 119 (47.60%) | 24 (30.77%) | 124 (45.93%) | 19 (32.76%) | ||
Cardioembolic | 118 (47.20%) | 50 (64.10%) | 131 (48.52%) | 37 (63.79%) | ||
Others | 13 (5.20%) | 4 (5.13%) | 15 (5.56%) | 2 (3.45%) | ||
Collateral score, median (IQR) | 0.00 (0.00–2.00) | 0.00 (0.00–1.00) | 0.183 | 0.00 (0.00–2.00) | 0.00 (0.00–1.00) | 0.015 |
OTR, median (IQR), min | 343.00 (277.75–440.00) | 337.00 (271.00–414.00) | 0.475 | 344.50 (278.75–440.25) | 340.50 (267.00–407.50) | 0.316 |
Number of passes, median (IQR) | 2.00 (1.00–3.00) | 2.00 (1.00–3.00) | 0.015 | 2.00 (1.00–3.00) | 2.00 (1.00–3.00) | 0.068 |
mTICI score 2b or 3, n (%) | 217 (86.80%) | 72 (92.31%) | 0.190 | 238 (88.15%) | 51 (87.93%) | 0.963 |
Eosinophils, 109/l; median (IQR) | 0.01 (0.00–0.04) | 0.00 (0.00–0.02) | < 0.001 | 0.01 (0.00–0.04) | 0.00 (0.00–0.00) | < 0.001 |
mRS score | 3.00 (1.00–4.00) | 6.00 (4.00–6.00) | < 0.001 | 3.00 (1.00–4.00) | 6.00 (5.00–6.00) | < 0.001 |
Poor outcome | 141 (56.40%) | 70 (89.74%) | < 0.001 | 156 (57.78%) | 55 (94.83%) | < 0.001 |